Medicare Enrolled
Dr. Roman Leibzon, M.D.
Interventional Cardiology · Burbank, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Leibzon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leibzon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Leibzon
Dr. Roman Leibzon is an interventional cardiology specialist in Burbank, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leibzon performed 6,254 Medicare services across 4,212 unique beneficiaries.
Between the years covered by Open Payments, Dr. Leibzon received a total of $3,123 from 11 pharmaceutical and/or device companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leibzon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in CA
$3,123 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,254
Medicare services
Top 18% in CA for interventional cardiology
4,212
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~313 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,445 | $104 | $858 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,164 | $12 | $111 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
712 | $175 | $1,382 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
548 | $43 | $451 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
376 | $148 | $960 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
223 | $101 | $680 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
203 | $7 | $43 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
196 | $76 | $2,030 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
181 | $206 | $1,312 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
178 | $54 | $517 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $128 | $1,085 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
127 | $11 | $72 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
127 | $22 | $121 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
123 | $147 | $1,320 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
98 | $410 | $3,251 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
77 | $49 | $221 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
49 | $10 | $259 |
| Cardiac catheterization | 41 | $214 | $1,610 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
36 | $36 | $294 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
25 | $6 | $68 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
25 | $178 | $1,800 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
24 | $238 | $1,163 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
21 | $18 | $150 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
21 | $12 | $76 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $71 | $432 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
19 | $181 | $856 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
18 | $8 | $25 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
15 | $24 | $143 |
| New patient office visit, complex (60-74 min) | 13 | $190 | $1,360 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.3% high complexity
20.5% medium
66.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,123
Total received (2018-2024)
Avg $521/year across 6 years
Bottom 36% in CA for interventional cardiology
11
Companies
31
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,077 (98.5%)
Other
Charitable contributions, space rental, and other categories
$33 (1.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$130
2023
$177
2022
$322
2021
$305
2020
$15
2018
$2,174
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$98
Baxter Healthcare
$33
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$1,760
Abbott Laboratories
$490
Medtronic, Inc.
$207
ABIOMED
$129
Amgen Inc.
$120
Novo Nordisk Inc
$118
Regeneron Healthcare Solutions, Inc.
$112
RedHill Biopharma Inc.
$98
Boston Scientific Corporation
$41
Baxter Healthcare
$33
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 78.7% of all-time payments
Associated products mentioned in payments ›
Azure · Claria MRI · DRAGONFLY OPSTAR · DUPIXENT · FARXIGA · HeartMate 3 Left Ventricular Dev · Impella · Micra · PERCLOSE PROGLIDE · PRESSUREWIRE · Protecta · Repatha · Resolute · Rotablator Rotational Atherectomy System Console Kit · SYNERGY · Saxenda · Talicia
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
84
Per 100K population
0.9
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Leibzon is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Leibzon experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leibzon performed 1,445 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leibzon receive payments from pharmaceutical companies?
Yes. Dr. Leibzon received a total of $3,123 from 11 companies across 31 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leibzon's costs compare to other interventional cardiologists in Burbank?
Dr. Leibzon's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leibzon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Burbank
Browse interventional cardiologists in Burbank ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology